MAPT and tauopathy: For example, the PS19 mouse model expresses P301S mutant human 1N/4R-Tau protein at approximately 5-fold higher levels than endogenous murine Tau, develops pathological and clinical abnormalities reflective of human tauopathy over a time course of months, and has provided numerous key insights into the pathogenesis of disease54–56.